YIH
RXDX

Y-Intercept (HK)’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Y-Intercept (HK)’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,623
Closed -$619K – 1655
2022
Q4 		$619K Buy
+5,623
New +$619K 0.09% 350